Cargando…

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma

Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to improve overall survival when combined with radiotherapy in the locally advanced setting or with chemotherapy in first-line...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leblanc, Olivia, Vacher, Sophie, Lecerf, Charlotte, Jeannot, Emmanuelle, Klijanienko, Jerzy, Berger, Frédérique, Hoffmann, Caroline, Calugaru, Valentin, Badois, Nathalie, Chilles, Anne, Lesnik, Maria, Krhili, Samar, Bieche, Ivan, Le Tourneau, Christophe, Kamal, Maud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142836/ https://www.ncbi.nlm.nih.gov/pubmed/32296588 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0153

Ejemplares similares

Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients
por: Neuzillet, Cindy, et al.
Publicado: (2021)

MMP2 as an independent prognostic stratifier in oral cavity cancers
por: Hoffmann, Caroline, et al.
Publicado: (2020)

Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas
por: Sablin, Marie-Paule, et al.
Publicado: (2016)

Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
por: Moreira, A., et al.
Publicado: (2021)

Thyroid cells seeding along the transaxillary approach after robot-assisted transaxillary surgery (RATS) for a benign node
por: Louvel, Rémy, et al.
Publicado: (2022)

Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma
por: Mainguené, Juliette, et al.
Publicado: (2022)

Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung Cancer
por: Basse, Clémence, et al.
Publicado: (2023)

Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
por: Kamal, Maud, et al.
Publicado: (2020)

Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
por: Kamal, Maud, et al.
Publicado: (2023)

Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types
por: Azorin, Paula, et al.
Publicado: (2022)

PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity
por: Hoffmann, Caroline, et al.
Publicado: (2022)

Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome
por: Kamal, Maud, et al.
Publicado: (2018)

Impact of cetuximab conventional dosing on cetuximab-induced magnesium concentration under haemodialysis in head and neck cancer
por: Thariat, Juliette, et al.
Publicado: (2008)

Mechanistic Signatures of Human Papillomavirus Insertions in Anal Squamous Cell Carcinomas
por: Morel, Adeline, et al.
Publicado: (2019)

Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
por: Gougis, Paul, et al.
Publicado: (2019)

Cytidine deaminase activity increases in the blood of breast cancer patients
por: Buhagiar-Labarchède, Géraldine, et al.
Publicado: (2022)

Author Correction: Cytidine deaminase activity increases in the blood of breast cancer patients
por: Buhagiar‑Labarchède, Géraldine, et al.
Publicado: (2022)

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
por: Tury, Sandrine, et al.
Publicado: (2016)

De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor
por: Morel, Adeline, et al.
Publicado: (2019)

Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer
por: Jeannot, Emmanuelle, et al.
Publicado: (2021)

Review of clinical applications of radiation-enhancing nanoparticles
por: Scher, N., et al.
Publicado: (2020)

Impact of the type of glucose monitoring on the assessment of glycemic variability in critical care patients
por: Kalfon, P, et al.
Publicado: (2012)

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer
por: Klinghammer, Konrad, et al.
Publicado: (2020)

Severe skin reaction secondary to concomitant radiotherapy plus cetuximab
por: Berger, Bernhard, et al.
Publicado: (2008)

Somatosensory Evoked Potentials in Predicting Motor Deficit after Ischemic or Hemorrhagic Stroke
por: CALUGARU, L., et al.
Publicado: (2015)

Evoked Potentials in Multiple Sclerosis Diagnosis and Management
por: CALUGARU, L., et al.
Publicado: (2016)

Romanian ophthalmologists in the renowned ophthalmic journals worldwide
por: Călugăru, Dan, et al.
Publicado: (2018)

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
por: Cizkova, Magdalena, et al.
Publicado: (2012)

Clinical and Molecular Insights of Radiation-Induced Breast Sarcomas: Is There Hope on the Horizon for Effective Treatment of This Aggressive Disease?
por: Kokkali, Stefania, et al.
Publicado: (2022)

Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer
por: Dahan, Laetitia, et al.
Publicado: (2011)

Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

The Prognostic Values of PARP-1 Expression in Uveal Melanoma
por: Gajdzis, Malgorzata, et al.
Publicado: (2021)

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials
por: Le Tourneau, Christophe, et al.
Publicado: (2015)

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020)

Efficacy of Liver Chemoembolization after Prior Cetuximab Monotherapy in Patients with Metastatic Colorectal Cancer
por: Szemitko, Marcin, et al.
Publicado: (2023)

Transgenic goats producing an improved version of cetuximab in milk
por: Laible, Götz, et al.
Publicado: (2020)

PIK3R1 underexpression is an independent prognostic marker in breast cancer
por: Cizkova, Magdalena, et al.
Publicado: (2013)

HDAC Inhibition to Prime Immune Checkpoint Inhibitors
por: Borcoman, Edith, et al.
Publicado: (2021)

Eales disease in a young adult man Case report
por: Călugăru, Dan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l1vi07nn1b2ri43lssbihukqtc